We have identified a number of shortcomings of the report on breast reconstruction after mastectomy, which we urge AHRQ to address before the report is finalized.
Read More »We’re Speaking Out on Health Issues
NCHR scientists and health policy experts provide written and oral statements on a wide range of topics.
Here are many of the ways we have been Speaking Out on Health Policy Issues for the last few years. Whether the topic is legislation intended to cure diseases, proposed bans on BPA or other chemicals that disrupt your hormones, the importance of including women, people of color, and patients over 65 in clinical trials, or many other topics, you’ll gain a better understanding of our evidence-based analyses by reading these letters, statements, and testimony.
Here are the ways we have been Speaking out on Medical Treatments and Products, such as prescription drugs and medical devices that the FDA is considering approving, or is considering taking off the market because of serious risks. Whether the topic is Chantix, Addyi, Yaz, Essure, or medical products you’ve never heard of, you can find out more about what is known and not known about the safety and effectiveness of a wide range of products by looking through this section of our website.
NCHR’s Testimony at FDA Regarding Donislecel Treatments for Diabetes
April 15, 2021: We agree with the concerns of the FDA reviewers regarding the benefit-risk profile of donislecel transplant treatments.
Read More »NCHR’s Comments on USPSTF’s Draft Recommendation for Diabetes Screening
While we agree that diabetes screening is an important tool, the USPSTF recommendation appears to be not fully rooted in data.
Read More »NCHR’s Testimony to NASEM Town Hall on PFAS Testing
We urge testing for blood levels of PFAS among those exposed at work, among communities exposed through groundwater, athletes and children who play on artificial turf and playground equipment, pregnant and lactating women, or others exposed to contaminants.
Read More »NCHR’s testimony to FDA on the OCS Heart System
April 6, 2021. The materials presented have not proven that the OSC Heart System is as effective or more effective than the usual standard of care.
Read More »


